Home › Gestational Diabetes › NCT06867861
Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes: A Randomized Controlled Trial
Who can join
Ages 18 to 50 · Women
Full eligibility criteria
Inclusion Criteria: * Singleton gestation * Known or new diagnosis of gestational diabetes without reason for medication * Age \>=18 to \<=50 Exclusion Criteria: * \- Non-English as primary language. * Known or suspected fetal anomaly or aneuploidy. * Known lower bowel disorder * Known phenylketonuria * Prisoners. * Management of diabetes outside of Eastern Virginia Medical School Maternal Fetal Medicine.
About the study
The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.
What is being tested
- Fiber (dietary supplement)
Sponsor: Eastern Virginia Medical School · Participants: 110 · Started: Feb 24, 2025
Contact the study team
Official record on ClinicalTrials.gov — NCT06867861
Locations in the U.S.
| Virginia | Macon & Joan Brock Virginia Health Sciences at ODU, Norfolk |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.